BioSpace News Archive

Corindus Vascular Robotics, Inc., a leading developer of precision vascular robotics, reported financial results for its second quarter ended June 30, 2019.

Cardinal Health reported fourth quarter fiscal year 2019 revenues of $37.4 billion, an increase of 6 percent from the fourth quarter last year.

AVROBIO, Inc. reported financial results for the second quarter ended June 30, 2019 and provided a business update.

Aerpio Pharmaceuticals, Inc., a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, reported financial results for the second quarter ended June 30, 2019, and provided a business update.

The American College of Medical Genetics and Genomics (ACMG) is announcing the establishment of an Evidence-Based Guidelines (EBG) Program, including a staff team dedicated to new evidence-based guideline development in the medical genetics and genomics field.

Agenus Inc., an immuno-oncology company with a pipeline of immune checkpoint antibodies, adoptive cell therapies1, and cancer vaccines provided corporate updates and reported financial results for the second quarter of 2019.

Ironwood Pharmaceuticals, Inc. (“Ironwood”) (Nasdaq: IRWD), a GI-focused healthcare company, today announced the pricing of $175 million aggregate principal amount of convertible senior unsecured notes that will mature on June 15, 2024 (the “2024 Notes”) and $175 million aggregate principal amount of convertible senior unsecured notes that will mature on June 15, 2026 (the “2026 Notes” and, together with the 2024 Notes, the “Notes”)

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has dosed the first patient in SEQUOIA (AROAAT2001), a potentially pivotal Phase 2/3 clinical study of ARO-AAT, the company’s second generation subcutaneously administered RNA interference (RNAi) therapeutic being developed as a treatment for a rare genetic liver disease associated with alpha-1 antitrypsin deficiency (AATD).

The global human vaccine market is expected to post a CAGR of close to 8% during the period 2018-2022, according to the latest market research report by Technavio.

cbdMD, Inc., a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), celebrates the second annual National CBD Day.